GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Capital Expenditure

Microbix Biosystems (Microbix Biosystems) Capital Expenditure : $-0.68 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Microbix Biosystems's cash flow for capital expenditures for the three months ended in Dec. 2023 was $-0.03 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.68 Mil.

Microbix Biosystems Capital Expenditure Historical Data

The historical data trend for Microbix Biosystems's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Capital Expenditure Chart

Microbix Biosystems Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 -0.62 -1.03 -1.52 -0.75

Microbix Biosystems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.40 -0.16 -0.09 -0.03

Microbix Biosystems Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems (Microbix Biosystems) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Capital Expenditure
Comparable Companies
TSXV:NRX TSX:BCT TSX:HBP TSXV:GSD XCNQ:GLAB TSXV:MIR TSX:MSCL TSXV:TTI XCNQ:DTC TSXV:COV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
MBX:Canada
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Website
https://www.microbix.com
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Microbix Biosystems (Microbix Biosystems) Headlines

From GuruFocus

Microbix Announces Annual and Special Meeting Voting Results

By GlobeNewswire GlobeNewswire • 04-01-2020

Microbix Attains Health Canada Establishment Licensing

By GlobeNewswire GlobeNewswire • 04-21-2020

Microbix Announces Extension of Warrant Expiry Date

By GlobeNewswire GlobeNewswire • 05-18-2023